Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2009
01/15/2009US20090018166 New Pyridine Analogues X 161
01/15/2009US20090018164 Farnesyl protein transferase inhibitors for treating breast cancer
01/15/2009US20090018163 Substituted Heterocyclic Ethers and Their Use in CNS Disorders
01/15/2009US20090018160 Heterocyclic Compounds with Affinity to Muscarinic Receptors
01/15/2009US20090018153 antiproliferative; cancer, psoriasis; increased bioavailability
01/15/2009US20090018152 Aminophenyl Derivatives as Novel Inhibitors of Histone Deacetylase
01/15/2009US20090018150 5-Ht2b Receptor Antagonists
01/15/2009US20090018145 Compositions and their use as anti-tumor agents
01/15/2009US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith
01/15/2009US20090018139 Treatment of CRTH2-mediated diseases and conditions
01/15/2009US20090018138 Treatment of CRTH2-mediated diseases and conditions
01/15/2009US20090018133 Novel Adamantane Derivatives
01/15/2009US20090018131 Quinazoline derivatives as p13 kinase inhibitors
01/15/2009US20090018124 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same
01/15/2009US20090018118 Heterocyclic compounds
01/15/2009US20090018112 Compounds and Uses Thereof
01/15/2009US20090018056 Heteroarylcarbamoylbenzene derivatives
01/15/2009US20090017441 Asymmetric cyanine fluorescent dyes
01/15/2009US20090017330 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
01/15/2009US20090017084 skin-friendly formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects, in particular imidacloprid, for controlling parasitic insects on animals
01/15/2009CA2692783A1 Quinazolinone t-type calcium channel antagonists
01/15/2009CA2692671A1 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
01/15/2009CA2692611A1 Di(arylamino)aryl compounds
01/15/2009CA2692374A1 Isothiazole and pyrazole derivatives as fungicides
01/15/2009CA2690756A1 Novel compounds as cannabinoid receptor ligands
01/15/2009CA2690349A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
01/15/2009CA2681624A1 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
01/14/2009EP2014657A1 Diaminopyrimidines as modulators for an EP2 receptor
01/14/2009EP2014656A2 New heteocyclic h3 antagonists
01/14/2009EP2014287A1 Use of cinnamic acid derivatives as modulators of an EP2 receptor
01/14/2009EP2013198A2 Solid-state form of amg 706 and pharmaceutical compositions thereof
01/14/2009EP2013197A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists
01/14/2009EP2013183A1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor
01/14/2009EP2013182A2 Aminoquinolones as gsk-3 inhibitors
01/14/2009EP2013181A1 Pyridyl compounds
01/14/2009EP2013174A2 Diaryl substituted alkanes
01/14/2009EP2013172A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder
01/14/2009EP2013170A1 4-squarylpiperazine derivatives as antiviral agents
01/14/2009EP1898917B1 Aminopyrimidines as kinase modulators
01/14/2009EP1789395B1 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
01/14/2009EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
01/14/2009EP1663974B1 2-pyridone derivatives as netrophil elastase inhibitors and their use
01/14/2009EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups
01/14/2009EP1560584B1 Fab i inhibitors
01/14/2009EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors
01/14/2009EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
01/14/2009EP1345899B1 N-substituted amides as NK1 receptor antagonists
01/14/2009EP1317443B1 Chemokine receptor binding heterocyclic compounds
01/14/2009EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
01/14/2009CN101346381A New anti-malaria derivatives of 4-aminoquinoline
01/14/2009CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
01/14/2009CN101346368A Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
01/14/2009CN101346360A Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
01/14/2009CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
01/14/2009CN101346141A Quinoline derivatives useful in the treatment of MGLUR5 receptor-mediated disorders
01/14/2009CN101343267A Preparation method for optical pure Pantoprazole
01/14/2009CN101343266A Preparation method for optical pure rebeprazole
01/14/2009CN101343251A Thrombopoietin mimetics
01/14/2009CN101343250A Thrombopoietin mimetics
01/14/2009CN101342169A Thrombopoietin mimetics
01/14/2009CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
01/14/2009CN100451015C Preparing method of imatinib
01/14/2009CN100451014C Process for making chiral 1,4-disubstituted piperazines
01/14/2009CN100450483C Stabilized pharmaceutical compositions contg. calcium channel blockers
01/14/2009CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
01/13/2009US7478376 Computer program code size partitioning method for multiple memory multi-processing systems
01/13/2009US7476746 PPAR active compounds
01/13/2009US7476688 Cyclic amidine derivatives
01/13/2009US7476685 Pyridine carboxamide derivatives and their use as pesticides
01/13/2009US7476683 Glycinamide derivatives as raf-kinase inhibitors
01/13/2009US7476682 N-substituted piperidine derivatives as serotonin receptor agents
01/13/2009US7476681 anticarcinogenic agent; prostate cancer, benign prostatic hyperplasia, prostatic intraepithelial neoplasia, hirsutism, acne, androgenic alopecia, or polycystic ovary syndrome, prostate, lung, pancreatic, colon, renal cancer, myeloid leukemia
01/13/2009US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents
01/13/2009US7476675 Quinolinone derivatives and uses thereof
01/13/2009US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology
01/13/2009US7476665 Benzodiazepine CGRP receptor antagonists
01/13/2009US7476663 Substituted thiophene carboxamides
01/13/2009CA2392902C Substituted bisindolylmaleimides for the inhibition of cell proliferation
01/13/2009CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
01/13/2009CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists
01/13/2009CA2293372C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
01/13/2009CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
01/08/2009WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers
01/08/2009WO2009006567A2 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
01/08/2009WO2009006389A2 Pyrimidine derivatives useful as raf kinase inhibitors
01/08/2009WO2009006255A1 Particulate (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of its use
01/08/2009WO2009006061A2 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
01/08/2009WO2009005729A1 Gamma secretase modulators
01/08/2009WO2009005674A2 Novel hiv reverse transcriptase inhibitors
01/08/2009WO2009005671A2 Substituted piperazines as cb1 antagonists
01/08/2009WO2009005646A2 Substituted piperazines as cb1 antagonists
01/08/2009WO2009005645A1 Substituted piperazines as cb1 antagonists
01/08/2009WO2009005471A1 Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors
01/08/2009WO2009005470A1 Aryl and heteroaryl substituted isoindole derivatives as bace inhibitors
01/08/2009WO2009005459A1 Phenyl-1,2, 3,4-tetrahydroisoquinolinone derivatives and their use in the treatment of a pain disorder
01/08/2009WO2009005076A1 Amide compound
01/08/2009WO2009005002A1 Quinolone derivative
01/08/2009WO2009004792A1 Sulfonamide compound, and crystal thereof
01/08/2009WO2009004650A1 Novel substituted piperidones as hsp inducers
01/08/2009WO2009004427A2 Benzimidazole derivatives